Literature DB >> 1904085

Soluble HLA-A2.1 restricted peptides that are recognized by influenza virus specific cytotoxic T lymphocytes.

M A Bednarek1, S A Engl, M C Gammon, J A Lindquist, G Porter, A R Williamson, H J Zweerink.   

Abstract

The influenza A virus matrix protein derived peptide with amino acids 57-68 (Lys-Gly-Ileu-Leu-Gly-Phe-Val-Phe-Thr-Leu-Thr-Val) is recognized by influenza virus HLA-A2 restricted CTL. Because of the large number of hydrophobic residues this peptide is very insoluble. Substitution with a number of polar amino acids resulted in a soluble peptide (Lys-Lys-Ala-Leu-Gly-Phe-Val-Phe-Thr-Leu-Asp-Lys) that was very effective in sensitizing HLA-A2 positive target cells. Further substitution of threonine in position 65 with lysine resulted in a soluble antagonist peptide that inhibited sensitization. Both agonist and antagonist peptides retained 20% of their biological activity when tyrosine was added at the N terminus. Soluble radio-iodinated peptides can now be prepared that will be useful reagents to study the interaction of peptides and class I molecules.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1904085     DOI: 10.1016/0022-1759(91)90349-k

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  6 in total

1.  Pre-existing T-cell immunity against mucin-1 in breast cancer patients and healthy volunteers.

Authors:  Brigitte Gückel; Christine Rentzsch; Maria-Dorothea Nastke; Alexander Marmé; Ines Gruber; Stefan Stevanović; Simone Kayser; Diethelm Wallwiener
Journal:  J Cancer Res Clin Oncol       Date:  2005-12-22       Impact factor: 4.553

2.  Human monocyte-derived macrophages and dendritic cells are comparably effective in vitro in presenting HLA class I-restricted exogenous peptides.

Authors:  L Toujas; J G Delcros; E Diez; N Gervois; G Semana; G Corradin; F Jotereau
Journal:  Immunology       Date:  1997-08       Impact factor: 7.397

3.  Immune reactions induced by interleukin-2 transfected colorectal cancer cells in vitro: predominant induction of lymphokine-activated killer cells.

Authors:  M Lindauer; H K Schackert; J Gebert; W Rudy; A Habicht; M Siebels; S C Meuer; U Moebius
Journal:  J Mol Med (Berl)       Date:  1996-01       Impact factor: 4.599

4.  Identification of HIV protein-derived cytotoxic T lymphocyte (CTL) epitopes for their possible use as synthetic vaccine.

Authors:  C Brander; W J Pichler; G Corradin
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

5.  Targeted delivery of peptide epitopes to class I major histocompatibility molecules by a modified Pseudomonas exotoxin.

Authors:  J J Donnelly; J B Ulmer; L A Hawe; A Friedman; X P Shi; K R Leander; J W Shiver; A I Oliff; D Martinez; D Montgomery
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 12.779

6.  Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment.

Authors:  P J Lehner; E C Wang; P A Moss; S Williams; K Platt; S M Friedman; J I Bell; L K Borysiewicz
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.